The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations ...

In a new study, adults 45 and up who got this seasonal virus had a higher risk of major heart issues, especially in the first ...

Federal regulators have begun a safety review of two RSV medicines used to protect infants, even though no safety problems ...

According to a recent report by CIDRAP and the CDC, published on November 24, 2025, viral activity is on the rise, and it's ...

U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective RSV treatments for infants would face fresh safety scrutiny following ...

The preventive therapies would be the latest called into question under U.S. Health Secretary Robert F. Kennedy Jr., a long-time promoter of anti-vaccine views.

Key Takeaways The U.S. Food and Drug Administration is reviewing two RSV drugs for infantsNo safety issues have been ...

Respiratory syncytial virus, commonly known as RSV, is often associated with cold-like symptoms in young children.

Federal health officials are reviewing the safety of two injectable drugs used to protect babies and toddlers from the RSV ...

Dr. Daniel Jernigan was the director of the National Center for Emerging and Zoonotic Infectious Diseases. He had worked at ...